Chenfei Zhou

Shanghai Key Laboratory Of Gastric Neoplasms
Shanghai, 200025, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

GLUT3 drives paclitaxel resistance in peritoneal metastatic gastric cancer by promoting H3K18 lactylation-mediated MAPKAP1 transcription to suppress ferroptosis.

GLUT3 drives paclitaxel resistance in peritoneal metastatic gastric cancer by promoting H3K18 lactylation-mediated MAPKAP1 transcription to suppress ferroptosis.

Journal: International journal of biological sciences

Published: December 16, 2025

A multicenter, observational study to evaluate the safety of restarting antitumor therapy recovered from COVID-19.

A multicenter, observational study to evaluate the safety of restarting antitumor therapy recovered from COVID-19.

Journal: Future oncology (London, England)

Published: December 03, 2025

Clinical and body composition parameters as predictors of response to chemotherapy plus PD-1 inhibitor in gastric cancer.

Clinical and body composition parameters as predictors of response to chemotherapy plus PD-1 inhibitor in gastric cancer.

Journal: Frontiers in immunology

Published: August 14, 2025

The Role of NADPH Oxidase 4 in Neutrophil-Mediated Immune Escape in Gastric Cancer.

The Role of NADPH Oxidase 4 in Neutrophil-Mediated Immune Escape in Gastric Cancer.

Journal: International journal of biological sciences

Published: July 18, 2025

Independent validation of the Mosamatic deep learning automated skeletal muscle and adipose tissue segmentation tool in an external Chinese cancer patient cohort.

Independent validation of the Mosamatic deep learning automated skeletal muscle and adipose tissue segmentation tool in an external Chinese cancer patient cohort.

Journal: BJR artificial intelligence

Published: May 29, 2025

Lenvatinib Plus Paclitaxel as Second-Line Therapy for Advanced Gastric Cancer Patients: A Dose Escalation Exploratory Study.

Lenvatinib Plus Paclitaxel as Second-Line Therapy for Advanced Gastric Cancer Patients: A Dose Escalation Exploratory Study.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 12, 2025

A phase Ia study of a novel anti-HER2 antibody-drug conjugate GQ1001 in patients with previously treated HER2 positive advanced solid tumors.

A phase Ia study of a novel anti-HER2 antibody-drug conjugate GQ1001 in patients with previously treated HER2 positive advanced solid tumors.

Journal: Journal of translational medicine

Published: August 26, 2024

A multidimensional recommendation framework for identifying biological targets to aid the diagnosis and treatment of liver metastasis in patients with colorectal cancer.

A multidimensional recommendation framework for identifying biological targets to aid the diagnosis and treatment of liver metastasis in patients with colorectal cancer.

Journal: Molecular cancer

Published: August 21, 2024

Preclinical investigations and a first-in-human phase 1a trial of JS007, a novel anti-CTLA-4 antibody, in patients with advanced solid tumors.

Preclinical investigations and a first-in-human phase 1a trial of JS007, a novel anti-CTLA-4 antibody, in patients with advanced solid tumors.

Journal: Experimental hematology & oncology

Published: June 24, 2024

Lipid metabolism associated with efficacy of metronomic capecitabine and camrelizumab in gastrointestinal cancer: an exploratory clinical trial.

Lipid metabolism associated with efficacy of metronomic capecitabine and camrelizumab in gastrointestinal cancer: an exploratory clinical trial.

Journal: BMC medicine

Published: June 21, 2024

Plasma Exosome Proteins ILK1 and CD14 Correlated with Organ-Specific Metastasis in Advanced Gastric Cancer Patients.

Plasma Exosome Proteins ILK1 and CD14 Correlated with Organ-Specific Metastasis in Advanced Gastric Cancer Patients.

Journal: Cancers

Published: July 04, 2023

Tumor-mesothelium HOXA11-PDGF BB/TGF β1-miR-181a-5p-Egr1 feedforward amplifier circuity propels mesothelial fibrosis and peritoneal metastasis of gastric cancer.

Tumor-mesothelium HOXA11-PDGF BB/TGF β1-miR-181a-5p-Egr1 feedforward amplifier circuity propels mesothelial fibrosis and peritoneal metastasis of gastric cancer.

Journal: Oncogene

Published: May 19, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026